170 related articles for article (PubMed ID: 16911519)
1. The role of electrostatic interactions in the antitumor activity of dimeric RNases.
Notomista E; Mancheño JM; Crescenzi O; Di Donato A; Gavilanes J; D'Alessio G
FEBS J; 2006 Aug; 273(16):3687-97. PubMed ID: 16911519
[TBL] [Abstract][Full Text] [Related]
2. [Why ribonucleases cause death of cancer cells].
Il'inskaia ON; Makarov AA
Mol Biol (Mosk); 2005; 39(1):3-13. PubMed ID: 15773542
[TBL] [Abstract][Full Text] [Related]
3. Biological Activities of Secretory RNases: Focus on Their Oligomerization to Design Antitumor Drugs.
Gotte G; Menegazzi M
Front Immunol; 2019; 10():2626. PubMed ID: 31849926
[TBL] [Abstract][Full Text] [Related]
4. Tandemization endows bovine pancreatic ribonuclease with cytotoxic activity.
Leich F; Köditz J; Ulbrich-Hofman R; Arnold U
J Mol Biol; 2006 May; 358(5):1305-13. PubMed ID: 16580680
[TBL] [Abstract][Full Text] [Related]
5. Second generation antitumour human RNase: significance of its structural and functional features for the mechanism of antitumour action.
Di Gaetano S; D'alessio G; Piccoli R
Biochem J; 2001 Aug; 358(Pt 1):241-7. PubMed ID: 11485573
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic ribonucleases and chimeras in cancer therapy.
Youle RJ; Newton D; Wu YN; Gadina M; Rybak SM
Crit Rev Ther Drug Carrier Syst; 1993; 10(1):1-28. PubMed ID: 8472310
[TBL] [Abstract][Full Text] [Related]
7. Intracellular route and mechanism of action of ERB-hRNase, a human anti-ErbB2 anticancer immunoagent.
De Lorenzo C; Di Malta C; Calì G; Troise F; Nitsch L; D'Alessio G
FEBS Lett; 2007 Jan; 581(2):296-300. PubMed ID: 17208233
[TBL] [Abstract][Full Text] [Related]
8. Interactions of the cytotoxic RNase A dimers with the cytosolic ribonuclease inhibitor.
Naddeo M; Vitagliano L; Russo A; Gotte G; D'Alessio G; Sorrentino S
FEBS Lett; 2005 May; 579(12):2663-8. PubMed ID: 15862306
[TBL] [Abstract][Full Text] [Related]
9. Natural and engineered ribonucleases as potential cancer therapeutics.
Arnold U; Ulbrich-Hofmann R
Biotechnol Lett; 2006 Oct; 28(20):1615-22. PubMed ID: 16902846
[TBL] [Abstract][Full Text] [Related]
10. A ribonuclease inhibitor resistant dimer of human pancreatic ribonuclease displays specific antitumor activity.
Attery A; Dey P; Tripathi P; Batra JK
Int J Biol Macromol; 2018 Feb; 107(Pt B):1965-1970. PubMed ID: 29042278
[TBL] [Abstract][Full Text] [Related]
11. The RNAse-RNAse inhibitor system in the liver of the frog Rana esculenta: subcellular distribution and differential binding of inhibitor with multiple RNAses.
Malicka-Błaszkiewicz M; Kubicz A
Acta Physiol Pol; 1981; 32(3):317-26. PubMed ID: 6975551
[TBL] [Abstract][Full Text] [Related]
12. [Ribonucleases as antiviral agents].
Il'inskaia ON; Shakh Makhmud R
Mol Biol (Mosk); 2014; 48(5):707-17. PubMed ID: 25842855
[TBL] [Abstract][Full Text] [Related]
13. Onconase dimerization through 3D domain swapping: structural investigations and increase in the apoptotic effect in cancer cells.
Fagagnini A; Pica A; Fasoli S; Montioli R; Donadelli M; Cordani M; Butturini E; Acquasaliente L; Picone D; Gotte G
Biochem J; 2017 Nov; 474(22):3767-3781. PubMed ID: 28963346
[TBL] [Abstract][Full Text] [Related]
14. Mung bean sprout (Phaseolus aureus) nuclease and its biological and antitumor effects.
Soucek J; Skvor J; Poucková P; Matousek J; Slavík T; Matousek J
Neoplasma; 2006; 53(5):402-9. PubMed ID: 17013534
[TBL] [Abstract][Full Text] [Related]
15. A role for the intersubunit disulfides of seminal RNase in the mechanism of its antitumor action.
Bracale A; Castaldi F; Nitsch L; D'Alessio G
Eur J Biochem; 2003 May; 270(9):1980-7. PubMed ID: 12709057
[TBL] [Abstract][Full Text] [Related]
16. A novel human antitumor dimeric immunoRNase.
Riccio G; Borriello M; D'Alessio G; De Lorenzo C
J Immunother; 2008 Jun; 31(5):440-5. PubMed ID: 18463541
[TBL] [Abstract][Full Text] [Related]
17. On the track of antitumour ribonucleases.
Benito A; Ribó M; Vilanova M
Mol Biosyst; 2005 Oct; 1(4):294-302. PubMed ID: 16880994
[TBL] [Abstract][Full Text] [Related]
18. A hydrophobic segment of some cytotoxic ribonucleases.
Shirshikov FV; Cherepnev GV; Ilinskaya ON; Kalacheva NV
Med Hypotheses; 2013 Aug; 81(2):328-34. PubMed ID: 23679997
[TBL] [Abstract][Full Text] [Related]
19. In vitro studies on selective inhibition of tumor cell growth by seminal ribonuclease.
Vescia S; Tramontano D; Augusti-Tocco G; D'Alessio G
Cancer Res; 1980 Oct; 40(10):3740-4. PubMed ID: 7438057
[TBL] [Abstract][Full Text] [Related]
20. Cytosolic RNase inhibitor only affects RNases with intrinsic cytotoxicity.
Monti DM; D'Alessio G
J Biol Chem; 2004 Sep; 279(38):39195-8. PubMed ID: 15277533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
